cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cerus Corp
9 own
17 watching
Current Price
$1.64
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
298.55M
52-Week High
52-Week High
3.08000
52-Week Low
52-Week Low
1.21000
Average Volume
Average Volume
0.45M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization298.55M
icon52-Week High3.08000
icon52-Week Low1.21000
iconAverage Volume0.45M
iconDividend Yield--
iconP/E Ratio--
What does the Cerus Corp do?
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company's INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was founded in 1991 and is headquartered in Concord, California.
Read More
How much money does Cerus Corp make?
News & Events about Cerus Corp.
Business Wire
10 months ago
Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2023. In 2005, the World Health Assembly designated June 14 as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. For...
Zolmax
1 year ago
StockNews.com upgraded shares of Cerus (NASDAQ:CERS Get Rating) from a sell rating to a hold rating in a research note published on Wednesday morning. A number of other research firms have also recently issued reports on CERS. BTIG Research cut Cerus from a buy rating to a neutral rating in a report...
Ticker Report
1 year ago
StockNews.com upgraded shares of Cerus (NASDAQ:CERS Get Rating) from a sell rating to a hold rating in a report published on Wednesday. Several other brokerages also recently issued reports on CERS. Stephens downgraded shares of Cerus from an overweight rating to an equal weight rating and ...
Business Wire
1 year ago
Cerus Corporation (Nasdaq: CERS) announced today that the Company will participate in two upcoming investor conferences. William Obi Greenman, Cerus president and chief executive officer, is scheduled to be in attendance at BTIGs MedTech, Digital Health, Life Science & Diagnostic Tools...
Zolmax
1 year ago
BTIG Research cut shares of Cerus (NASDAQ:CERS Get Rating) from a buy rating to a neutral rating in a research note published on Friday morning, MarketBeat Ratings reports. CERS has been the subject of several other research reports. Stephens lowered Cerus from an overweight rating to an equal ...
Frequently Asked Questions
Frequently Asked Questions
What is Cerus Corp share price today?
plus_minus_icon
Can Indians buy Cerus Corp shares?
plus_minus_icon
How can I buy Cerus Corp shares from India?
plus_minus_icon
Can Fractional shares of Cerus Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Cerus Corp stocks?
plus_minus_icon
What is today’s traded volume of Cerus Corp?
plus_minus_icon
What is today’s market capitalisation of Cerus Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Cerus Corp?
plus_minus_icon
What percentage is Cerus Corp down from its 52-Week High?
plus_minus_icon
What percentage is Cerus Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$1.64
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00